The NBOMe series: a novel, dangerous group of hallucinogenic drugs
Ninnemann, A.; Stuart, G.L.
Journal of studies on alcohol and drugs 74(6): 977-978
2013
ISSN/ISBN: 1938-4114 PMID: 24172126 Document Number: 669015
Document emailed within 1 workday
Related Documents
Tonge, S.R.; Leonard, B.E. 1972: Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism Archives Internationales de Pharmacodynamie et de Therapie 195(1): 168-176Bignell, C.M.; Dunlop, P.J.; Brophy, J.J.; Jackson, J.F. 1996: Volatile leaf oils of some south-western and southern Australian species of genus Eucalyptus (Series I). Part XIII. (Series I). (a) Series Subulatae, (b) Series Curviptera, (c) Series Contortae, (d) Series Incognitae, (e) Series Terminaliptera, (f) Series Inclusae, (g) Series Microcorythae and (h) Series Cornutae Flavour and Fragrance Journal 11(6): 339-347
Logan, W.J. 1975: Neurological aspects of hallucinogenic drugs Advances in Neurology 13: 47-78
Bellman, S.W.; Turczan, J.W.; Kram, T.C. 1970: Spectrometric forensic chemistry of hallucinogenic drugs Journal of Forensic Sciences 15(2): 261-286
Sindelár, K.; Metysová, J.; Protiva, M. 1973: A new group of highly potent neuroleptic drugs in the series of 10-piperazi nodibenzo (b,f) thiepins: 8-Acyl derivatives of perathiepin (chemistry and pharmacology) Activitas Nervosa Superior 15(2): 97-98
Haan, J. 1981: Drug dependence. a review of the narcotic and hallucinogenic effects of drugs Medizinische Monatsschrift für Pharmazeuten 4(5): 129-137
2015: New drugs and indications in 2014. Some advances this year, but many drugs are poorly evaluated, too expensive, or more dangerous than useful Prescrire International 24(159): 107-110
Omelka, M. 1997: Unauthorized manufacture and possession of hallucinogenic and psychotropic drugs and poisons. Present laws and possible de lege ferende solutions Casopis Lekaru Ceskych 136(21): 674-677
Romano, A. 1973: Report on drugs, narcotic and dangerous Journal - Association of Official Analytical Chemists 56(2): 263-264
Heilmann, K. 1984: How dangerous are pain and rheumatism drugs? Fortschritte der Medizin 102(18): 76-77
Isal, J.P.; Caulin, C. 1979: Dangerous drugs in hepatic insufficiency Medecine and Chirurgie Digestives 8(5): 447-449
Trulson, M.E.; Preussler, D.W.; Trulson, V.M. 1984: Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats Journal of Pharmacology and Experimental Therapeutics 228(1): 94-102
Garfield, F.M. 1970: Federal plan for narcotics and dangerous drugs Bulletin of the Parenteral Drug Association 24(1): 11-13
Kamijo, Y. 2016: Dangerous drugs: products containing synthetic chemicals Nihon Rinsho. Japanese Journal of Clinical Medicine 74(2): 241-244
Sohn, W. 2003: Prescribing narcotics--fact and fiction against the background of the Dangerous Drugs Act MMW Fortschritte der Medizin 145(13): 40-41
Amon, J.J. 2008: Dangerous medicines: unproven AIDS cures and counterfeit antiretroviral drugs Globalization and Health 4: 5
Yang, C; Southwell, B G. 2004: Dangerous disease, dangerous women: health, anxiety and advertising in Shanghai from 1928 to 1937 Critical Public Health 14(2): 149-156
Kozulitsyna, T.I.; Kozlova, N.V. 1976: Effectiveness of the drugs of streptomycin group in experimental studies on albino mice infected with Mycobacterium tuberculosis resistant to these drugs Problemy Tuberkuleza 9: 70-74
Kamijo, Y. 2015: Demographics, clinical features, treatments, and outcomes of patients who were transferred to emergency facilities in Japan after consuming dangerous drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 73(9): 1497-1500
Fredholm, B.B. 1997: New series: action mechanisms of drugs Lakartidningen 94(19): 1787-1788